Trials / Completed
CompletedNCT03701516
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 268 (actual)
- Sponsor
- Johnson & Johnson Vision Care, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
This study is a multi-site, group sequential, adaptive, randomized, double-masked, 2×2 crossover design, 1-week dispensing study. Subjects will wear bilaterally both Test and Control lenses in a random order for 1-week each as a daily disposable modality with a wash-out period of 1 week between the wearing periods.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | etafilcon A with novel molding process | TEST Lens |
| DEVICE | etafilcon A with current molding process | CONTROL Lens |
Timeline
- Start date
- 2018-09-24
- Primary completion
- 2019-04-01
- Completion
- 2019-04-01
- First posted
- 2018-10-10
- Last updated
- 2022-04-27
- Results posted
- 2022-04-27
Locations
12 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03701516. Inclusion in this directory is not an endorsement.